biote Corp. (BTMD) Misses Q2 EPS by 35c; Offers FY23 Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Biote Reports Second Quarter 2023 Financial Results
August 10, 2023 4:30 PM EDTSolid Second Quarter Revenue Growth
Continued Progress to Optimize Capital Structure and Enhance Share Liquidity
Expansive Strategic Approach Targeting Therapeutic Wellness and Mens Health Categories
IRVING, Texas--(BUSINESS WIRE)-- Biote (NASDAQ: BTMD), a leading solutions provider in preventive health care through the delivery of personalized hormone therapy,... More



